Jae Min Kim

Title: Jae Min Kim: Innovator in Pharmaceutical Compounds

Introduction

Jae Min Kim is a notable inventor based in Clarksburg, MD (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for treating various disorders. With a total of 2 patents, his work is recognized for its potential impact on medical treatments.

Latest Patents

Jae Min Kim's latest patents focus on Tetrahydroisoquinolin-2-yl-(quinazolin-4-yl)methanone compounds. These patents describe pharmacologically acceptable salts and compositions containing such compounds. Additionally, methods for treating hyperproliferative disorders through the administration of these compounds are outlined. His work also includes the development of 1,2,3,4-tetrahydroisoquinoline derivatives for creating the aforementioned compounds.

Career Highlights

Jae Min Kim is currently associated with Rexahn Pharmaceuticals, Inc., where he continues to advance his research and development efforts. His innovative approach to pharmaceutical compounds has positioned him as a key player in the industry.

Collaborations

Throughout his career, Jae Min Kim has collaborated with notable colleagues, including Young Bok Lee and Deog Joong Kim. These partnerships have contributed to the success of his research and the advancement of their shared goals in the pharmaceutical field.

Conclusion

Jae Min Kim's contributions to pharmaceutical innovations highlight his expertise and dedication to improving medical treatments. His patents and ongoing research continue to pave the way for advancements in the industry.